GenSight Biologics S.A. (GSGTF)

USD 0.24

(-92.26%)

Revenue Summary of GenSight Biologics S.A.

  • GenSight Biologics S.A.'s latest annual revenue in 2023 was 1.26 Million EUR , up 19.82% from previous year.
  • GenSight Biologics S.A.'s latest quarterly revenue in 2024 Q2 was 1.16 Million USD , down 0.0% from previous quarter.
  • GenSight Biologics S.A. reported a annual revenue of 2.76 Million USD in annual revenue 2022, down -53.92% from previous year.
  • GenSight Biologics S.A. reported a annual revenue of 5.99 Million USD in annual revenue 2021, up 11.54% from previous year.
  • GenSight Biologics S.A. reported a quarterly revenue of 1.69 Million USD for 2023 Q2, down 0.0% from previous quarter.
  • GenSight Biologics S.A. reported a quarterly revenue of 1.6 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of GenSight Biologics S.A. (2023 - 2013)

Historical Annual Revenue of GenSight Biologics S.A. (2023 - 2013)

Year Revenue Revenue Growth
2023 1.26 Million EUR 19.82%
2022 2.76 Million USD -53.92%
2021 5.99 Million USD 11.54%
2020 5.37 Million USD 584.22%
2019 785.74 Thousand USD -84.22%
2018 4.97 Million EUR 12.1%
2017 4.44 Million EUR 40.62%
2016 3.15 Million EUR -18.31%
2015 3.86 Million EUR 189.68%
2014 1.33 Million EUR 6.69%
2013 1.25 Million EUR 0.0%

Peer Revenue Comparison of GenSight Biologics S.A.

Name Revenue Revenue Difference
Capstone Therapeutics Corp. 48.35 Million USD 97.38%
Skye Bioscience, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 98.97%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -1573.182%
BioStem Technologies, Inc. 16.68 Million USD 92.407%
Regen BioPharma, Inc. 236.56 Thousand USD -435.594%
CSL Limited 14.69 Billion USD 99.991%
Northwest Biotherapeutics, Inc. 1.93 Million USD 34.42%
Evofem Biosciences, Inc. 18.21 Million USD 93.045%
Rebus Holdings, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -92.407%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 91.967%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -7090.284%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 94.101%
Intellipharmaceutics International Inc. 65.72 Thousand USD -1827.641%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 78.533%
Marizyme, Inc. 645.81 Thousand USD -96.188%
Genus plc 668.8 Million USD 99.811%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.484%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -1179.876%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -208.9%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -1550.578%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -3106.134%
MultiCell Technologies, Inc. 49.32 USD -2568837.551%
ONE Bio Corp. 52.29 Million USD 97.577%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 97.452%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -2491.002%
Q BioMed Inc. 284.35 Thousand USD -345.574%
Emmaus Life Sciences, Inc. 29.59 Million USD 95.719%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.127%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -127.179%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -1710.0%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -126726.827%
Enzolytics Inc. 52.79 Thousand USD -2299.803%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -108.208%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.897%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -803.438%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -105.221%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.849%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -26.989%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -435.594%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 7.451%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -167.452%
SYBLEU INC 11.69 Thousand USD -10732.763%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 83.733%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -9646.154%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -3104.836%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 61.952%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 80.99%
IntelGenx Technologies Corp. 1.03 Million USD -21.944%
Gelesis Holdings, Inc. 25.76 Million USD 95.083%
CSL Limited 14.8 Billion USD 99.991%
Cellectis S.A. 755 Thousand USD -67.815%